Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells.

NAD(P)H:quinone oxidoreductase 1 (NQO1) is implicated in both chemoprevention and bioactivation of DNA-damaging antitumor agents. NQO1 is mainly cytosolic, but distribution in other cellular compartments, particularly in tumor cells, is poorly defined. Nuclear NQO1 in HT29 human colon carcinoma and H661 human non-small cell lung cancer cells was observed using both confocal microscopy and immunoelectron microscopy. NQO1 was not detected in mitochondria, golgi, or endoplasmic reticulum. In addition, purified intact nuclei from HT29 cells contained immunoreactive NQO1, which was catalytically active as determined by conventional activity assay. In summary, we have confirmed the presence of nuclear NQO1, which has implications for chemoprotection and bioactivation of DNA-damaging antitumor agents.

[1]  L. Landi,et al.  DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. , 1997, Free radical biology & medicine.

[2]  P. Talalay,et al.  Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Liebler,et al.  The Reduction of α-Tocopherolquinone by Human NAD(P)H:Quinone Oxidoreductase: The Role of α-Tocopherolhydroquinone as a Cellular Antioxidant , 1997 .

[4]  R. Larson,et al.  Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. , 1999, Blood.

[5]  K. McDonald,et al.  Electron microscopy and EM immunocytochemistry. , 1994, Methods in cell biology.

[6]  D. Ross,et al.  Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. , 2001, Molecular pharmacology.

[7]  G. Powis,et al.  Cytosolic NAD(P)H:(Quinone‐acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol , 1990, International journal of cancer.

[8]  T. Cresteil,et al.  High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. , 1991, Biochemical pharmacology.

[9]  L. Ernster,et al.  DT diaphorase. II. Relation to respiratory chain of intact mitochondira. , 1962, Biochimica et biophysica acta.

[10]  S. Nadler,et al.  Intranuclear targeted delivery of functional NF‐κB by 70 kDa heat shock protein , 1999 .

[11]  Xi,et al.  Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. , 1997, Cancer research.

[12]  G. Morgan,et al.  Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. , 2001, Blood.

[13]  E. Nagoshi,et al.  Nucleocytoplasmic protein transport and recycling of Ran. , 1999, Cell structure and function.

[14]  Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. , 1999 .

[15]  A. Tomida,et al.  DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines. , 1996, Cancer research.

[16]  G. Dallner,et al.  Distribution of newly synthesized DT-diaphorase in rat liver , 1982, Bioscience reports.

[17]  M. Spitz,et al.  Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. , 1997, British Journal of Cancer.

[18]  Juan Segura-Aguilar,et al.  Activity and immunohistochemistry of DT-diaphorase in hamster and human kidney tumours. , 1994, Carcinogenesis.

[19]  A. Malkinson,et al.  Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł. , 1992, Cancer research.

[20]  J. Lear,et al.  Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. , 1999, Carcinogenesis.

[21]  L. Landi,et al.  The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Depierre,et al.  Levels and subcellular distributions of detoxifying enzymes in the ovarian corpus luteum of the pregnant and non-pregnant pig. , 1999, Biochemical pharmacology.

[23]  Lars Ernster.  [56] DT diaphorase , 1967 .

[24]  D. Ross,et al.  Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. , 1994, Oncology research.

[25]  D. Ross,et al.  DT-diaphorase in activation and detoxification of quinones , 1993, Cancer and Metastasis Reviews.

[26]  D. Ross,et al.  Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. , 2001, Biochemical pharmacology.

[27]  M. Bukrinsky,et al.  Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. , 2000, Experimental cell research.

[28]  J. Lotem,et al.  Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.